1 – 50 of 102
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Primary prophylaxis implementation and long-term joint outcomes in Swedish haemophilia A patients
2024) In Haemophilia(
- Contribution to journal › Article
-
Mark
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B
2024) In Haemophilia(
- Contribution to journal › Article
- 2023
-
Mark
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A – A modified Delphi consensus by the ADVANCE Working Group
(
- Contribution to journal › Scientific review
-
Mark
Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A
(
- Contribution to journal › Article
- 2021
-
Mark
Comparison of single subject and population-based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A
(
- Contribution to journal › Article
-
Mark
A comparison of MyPKFiT and WAPPS-Hemo as dosing tools for optimizing prophylaxis in patients with severe haemophilia A treated with Octocog alfa
(
- Contribution to journal › Article
-
Mark
Recombinant FVIIa in elective non-orthopaedic surgery of adults with haemophilia and inhibitors : A systematic literature review
(
- Contribution to journal › Scientific review
-
Mark
Translating the success of prophylaxis in haemophilia to von Willebrand disease
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Achieving the unimaginable : Health equity in haemophilia
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Factor VIII : Long-established role in haemophilia A and emerging evidence beyond haemostasis
(
- Contribution to journal › Scientific review
-
Mark
Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram : A Nordic study
(
- Contribution to journal › Article
-
Mark
Hypertension and cardiovascular diseases in Swedish persons with haemophilia — A longitudinal registry study
(
- Contribution to journal › Article
- 2018
-
Mark
How I manage patients with inherited haemophilia A and B and factor inhibitors
(
- Contribution to journal › Scientific review
-
Mark
Advantages, disadvantages and optimization of one-stage and chromogenic factor activity assays in haemophilia A and B
(
- Contribution to journal › Scientific review
-
Mark
The role of the laboratory in diagnosis and management of inhibitory antibodies in haemophilia
(
- Contribution to journal › Article
- 2017
-
Mark
The impact of clinical practice on the outcome of central venous access devices in children with haemophilia
(
- Contribution to journal › Article
-
Mark
Preference-based valuation of treatment attributes in haemophilia A using web survey
(
- Contribution to journal › Article
-
Mark
Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy : The Malmö experience
(
- Contribution to journal › Article
-
Mark
Plasma-derived versus recombinant factor concentrates in PUPs : A never ending debate?
(
- Contribution to journal › Article
-
Mark
Register-based studies to assess long-term outcome in haemophilia
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Low agreement between fresh and frozen-thawed platelet-rich plasma in the calibrated automated thrombogram assay
(
- Contribution to journal › Article
-
Mark
The importance of genetic factors for the development of arthropathy : A longitudinal study of children and adolescents with haemophilia A
(
- Contribution to journal › Article
-
Mark
The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany
(
- Contribution to journal › Article
- 2016
-
Mark
Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe
(
- Contribution to journal › Article
-
Mark
The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands
(
- Contribution to journal › Article
-
Mark
SPINART study : validation of the extended magnetic resonance imaging scale for evaluation of joint status in adult patients with severe haemophilia A using baseline data
(
- Contribution to journal › Article
-
Mark
The effect of Nordic Walking on joint status, quality of life, physical ability, exercise capacity and pain in adult persons with haemophilia
(
- Contribution to journal › Article
-
Mark
Future of haemophilia outcome assessment : Registries are key to optimized treatment
(
- Contribution to journal › Article
-
Mark
Haemophilia treatment in 2030
(
- Contribution to journal › Article
-
Mark
Current view and outcome of ITI therapy : A change over time?
(
- Contribution to journal › Article
- 2015
-
Mark
Haemophilia in Sweden – Studies on mutations and clinical implications
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Co-morbidity and mortality in Swedish patients with haemophilia - A register study
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The ageing patient with haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Various regimens for prophylactic treatment of patients with haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand
(
- Contribution to journal › Article
-
Mark
Genetic risk factors for inhibitors in haemophilia A
(
- Contribution to journal › Scientific review
-
Mark
Switching treatments in haemophilia: is there a risk of inhibitor development?
(
- Contribution to journal › Scientific review
-
Mark
Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events
(
- Contribution to journal › Scientific review
-
Mark
Non-genetic risk factors and their influence on the management of patients in the clinic
(
- Contribution to journal › Scientific review
-
Mark
Interaction between VWF and FVIII in treating VWD
(
- Contribution to journal › Article
-
Mark
Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical studies
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Methods for individualising factor VIII dosing in prophylaxis
(
- Contribution to journal › Scientific review
-
Mark
On-demand treatment in persons with severe haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Managing Haemophilia for Life: 4th Haemophilia Global Summit
(
- Contribution to journal › Scientific review
-
Mark
Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review
(
- Contribution to journal › Scientific review
-
Mark
Perinatal aspects of haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Outcome measures in haemophilia: a systematic review
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Health-Related Quality of Life and Adherence in Haemophilia
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Progressive improvement in wound healing with increased therapy in haemophilia B mice
(
- Contribution to journal › Article
-
Mark
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study
(
- Contribution to journal › Article